ID: ALA5280945

Max Phase: Preclinical

Molecular Formula: C18H19N5

Molecular Weight: 305.39

Associated Items:

Representations

Canonical SMILES:  CCCCn1cnc2c(Cc3cccc(C)c3)nc(C#N)nc21

Standard InChI:  InChI=1S/C18H19N5/c1-3-4-8-23-12-20-17-15(21-16(11-19)22-18(17)23)10-14-7-5-6-13(2)9-14/h5-7,9,12H,3-4,8,10H2,1-2H3

Standard InChI Key:  QOTNQMXDCXJKBX-UHFFFAOYSA-N

Associated Targets(non-human)

Trypanosoma brucei 78846 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 305.39Molecular Weight (Monoisotopic): 305.1640AlogP: 3.40#Rotatable Bonds: 5
Polar Surface Area: 67.39Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.25CX LogD: 4.25
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.72Np Likeness Score: -1.19

References

1. Rocha DA, Silva EB, Fortes IS, Lopes MS, Ferreira RS, Andrade SF..  (2018)  Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors.,  157  [PMID:30282318] [10.1016/j.ejmech.2018.08.079]

Source